The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Estrella Immunopharma Inc formerly known as TradeUP Acquisition Corp NASDAQ UPTD UPTDW UPTDU has successfully completed its merger with Estrella Biopharma Inc a preclinicalstage biopharmaceutical company specializing in Tcell therapies for blood canc...
QurisAI an innovative player in the pharmaceutical industry powered by artificial intelligence AI has announced the expansion of its collaboration with Merck KGaA Darmstadt Germany a prominent science and technology company
ImmunoGenesis has recently announced the initiation of its Phase ab clinical trial for its lead candidate IMGS at The University of Texas MD Anderson Cancer Center in Houston Texas
NorthX Biologics AB is excited to announce the official opening of its advanced Innovation Hub located at the Matfors facility
Smart Immune a clinicalstage biotechnology company focusing on the development of ProTcell a Tcell progenitor therapy platform designed to swiftly rejuvenate the immune system has officially initiated its ReSET Phase III trial for adult acute leukemi...
Pathios Therapeutics Limited a biotechnology company dedicated to advancing innovative cancer therapies has been awarded a grant of equivalent to approximately US from Innovate UK
GenSight Biologics Euronext SIGHT ISIN FR PEAPME eligible has provided an update regarding its discussions with the European Medicines Agency EMA on the design of a new Phase III trial for LUMEVOQ
Novo Nordisk and Evotec SE have introduced LAB eN a novel program designed to accelerate earlystage research originating from academic institutions with a primary focus on addressing unmet needs in cardiometabolic diseases rare blood disorders and ra...
Chrysalis BioTherapeutics Inc made an announcement today regarding the approval from the US Food and Drug Administration FDA to commence human clinical trials aimed at treating acute lung failure
Laboratoires Pierre Fabre and Vernalis RD Ltd a whollyowned subsidiary of HitGen Inc are excited to announce a longterm collaboration aimed at the discovery of preclinical candidates for a variety of oncological targets
